Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 28 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7928107

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  2. US 7919520

    Inhibitors of tace

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  3. US 7919513

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  4. US 7919523

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  5. US 7915385

    Sodium channel protein type III α-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  6. US 7915305

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  7. US 7906550

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  8. US 7906650

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  9. US 7902239

    Diaminotriazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  10. US 7888384

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  11. US 7884199

    HCV NS3-NS4 protease resistance mutants

    Vertex Pharmaceuticals Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  12. US 7883881

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  13. US 7879891

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  14. US 7879834

    Spiroindoline modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  15. US 7880008

    Heterocycles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  16. US 7880007

    Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  17. US 7875712

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  18. US 7872031

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  19. US 7872129

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  20. US 7863449

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  21. US 7863282

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  22. US 7858790

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  23. US 7858635

    Spiro compounds as modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  24. US 7858786

    Pyrimidines and pyrazines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.